Vinamilk Showcases Science-Driven Innovation and Wins Prestigious Awards at Global Dairy Congress 2025
A Highlight of Science-Based Nutrition at GDC-18
Held in Amsterdam, Netherlands, 18th Global Dairy Congress brought together nearly 200 industry leaders to explore emerging trends and the future of the global dairy sector. Under the theme "Dairy for All Ages", the event focused on inclusive nutrition, innovation, and sustainable solutions to serve consumers at every life stage.
As the sole representative from Southeast Asia to deliver a presentation, Vinamilk marked its fifth appearance at the event, highlighting how advanced technology and scientific applications unlock and enhance nature's gifts, reinforcing its commitment to industry excellence.
At GDC 2025, a premier global platform for the dairy industry, Vinamilk showcased cutting-edge dairy products under the theme "Born by Nature, Perfected by Science", demonstrating its innovation strategy to preserve and enhance the natural value of dairy while meeting diverse health and nutrition needs. Highlighted products included the Green Farm's product line, Vinamilk Optimum, and Plant-Based Milk.
Green Farm was featured as a case study in harnessing nature's potential through advanced dairy technology. Its proprietary air-sealed technology reduces free oxygen radicals in milk by up to 50%, preserving freshness, floral aroma, and natural taste. Using European ultra-filtration technology, Green Farm High Protein Milk offers a smart, additive-free nutritional solution: high protein, rich calcium, low fat, and lactose-free meeting the rising demand for personalized nutrition. Meanwhile, Green Farm Drinking Yogurt is the first and only product in Vietnam to include six European probiotic strains, delivering 720 million live cultures that boost flavor and digestive health.
A key scientific breakthrough was also emphasized with Vinamilk Optimum, an exclusive infant formula inspired by breast milk. For the first time in Vietnam, it incorporates six Human Milk Oligosaccharides (HMOs), representing 58% of the total HMO content found in breast milk, the highest concentration available in the market. Furthermore, Vinamilk also became Southeast Asia's first dairy producer to adopt Tetra Pak's wholesome soy grinding technology, enhancing soy nutrition, and reducing waste in line with its sustainability goals.
Building on Vinamilk's science-led approach that unites nature and technology, Dr. Richard Hall, Chairman and Founder of the Global Dairy Congress, remarked: "Dairy has long been a cornerstone of nutrition, but it must keep evolving to meet human needs. We cannot consume hundreds of products at once—we have to choose what's 'best for me.' Now more than ever, technology is empowering the dairy industry to go further and last longer."
From Emerging Market to Global Player
At this year's congress, Vinamilk was honored with two distinguished awards at the 2025 World Dairy Innovation Awards. Its Green Farm High-Protein Greek Yogurt was named Best Yogurt, while the Plant-Based Vinamilk Yogurt received the award for Best Packaging Design. These achievements underscore Vinamilk's unwavering commitment to innovation and creativity in the global dairy industry.
Although relatively young, Vietnam's dairy industry has undergone a remarkable transformation over the past five decades with Vinamilk at the forefront of modernizing production and advancing science-based nutrition.
"By honoring the essence of nature and enriching it with cutting-edge science, we remain committed to delivering nutritious products that stay true to their natural origins—in both taste and nourishment. Our journey of relentless innovation, guided by our mission 'Care to make it real,' is devoted to consumer health and to shaping a sustainable, world-class dairy industry for Vietnam," said Nguyen Quang Tri, Chief Marketing Officer of Vinamilk.
In 2024 alone, Vinamilk introduced 125 new products—about one every two working days—reflecting both its responsiveness to personalized nutrition trends and its commitment to global standards. As a result, this innovation has earned international acclaim, including the Monde Selection (EU), Superior Taste Award (EU), and Clean Label Project Certification (USA), placing Vietnamese dairy on par with global quality benchmarks.
With a strong global network of partners, 17 factories, and 15 internationally certified farms, Vinamilk integrates advanced technology across its entire supply chain to preserve nutrition, ensure safety, and elevate product quality. Established in 1976, Vinamilk is not only Vietnam's No.1 dairy brand, but also exports to over 65 countries, ranks among the Top 36 global dairy companies by revenue, and is recognized as the 6th most valuable dairy brand in the world.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
2 hours ago
- Korea Herald
Maldives and Henley & Partners Sign Landmark Partnership Agreement to Launch Pioneering Residence by Investment Program
MALÉ, Maldives, July 1, 2025 /PRNewswire/ -- The Government of the Maldives has signed a landmark partnership agreement with Henley & Partners, the world's leading international investment migration advisory firm, to develop and implement the nation's first-ever residence by investment program. This groundbreaking collaboration supports President Dr. Mohamed Muizzu's Vision 2040, which aims to transform the Maldives into a fully developed, resilient, and diversified economy. Mr. Mohamed Saeed, Minister of Economic Development and Trade, speaking at the sidelines of the signing ceremony which was held at the Maldives–Singapore Business Forum 2025 on Sentosa Island in Singapore, said: "The Maldives has long been a world-class destination for travelers. With this program, we aim to extend that legacy to discerning global investors who see value in our people, our potential, and our future. This partnership with Henley & Partners reflects our confidence in aligning with reputable global players to achieve economic diversification and national resilience under President Dr. Mohamed Muizzu's visionary leadership and Vision 2040 targets." Recognized globally as one of the world's most iconic luxury destinations, the Maldives intends to offer discerning global investors a unique opportunity to establish long-term residence in what is often described as a tropical paradise, comprising of 1,190 Coral Islands each surrounded by crystal-blue lagoons and grouped in a double chain of 27 atolls and spread over roughly 90,000 square kilometers. Philippe Amarante, Managing Partner and Head of Government Advisory EMEA at Henley & Partners, told guests attending the ceremony that the new investment migration program will capitalize on the country's world-class real estate offerings. "The residence by investment program will provide state-of-the-art properties with the utmost privacy and exclusivity. As a safe, stable, and peaceful island nation, the Maldives presents the ultimate hedge against geopolitical conflict or global pandemics, offering an unparalleled lifestyle and security to high-net-worth individual investors and their families."
Korea Herald
2 hours ago
- Korea Herald
FHC Shanghai 2025 Opens Global Gateway to China's Food Market
SHANGHAI, July 1, 2025 /PRNewswire/ -- The 28th edition of FHC Shanghai Global Food Trade Show will return to the Shanghai New International Expo Centre (SNIEC) from November 12–14, 2025. As Asia's premier food and beverage trade platform, FHC Shanghai will be held by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. which connects 3,000+ exhibitors from 100+ countries with 180,000+ professional buyers, solidifying its role as the critical gateway for global brands entering China's $1.5 trillion food market. Spanning 200,000 SQM the exhibition will showcase 15 product sectors including Meat, Sea Food, Leisure Food & Beverage, Dairy, Sweets & Chocolate, Catering Supply Chain & Raw Material, Condiments & Oil, Coffee & Tea, Bakery & Light Meal, Food Processing & Packaging, Prefabricated Dishes & Central Kitchen, Canned Food & Raw Materials, Machinery and Equipment, Hot Pot Ingredients and Supplies, Homology of Medicine and Food, Baby Food. The 2024 event drew record participation with pavilions from 50+ countries & regions, and FHC 2025 announces its first wave of international pavilions: representing Italy, Japan, Spain, Türkiye, Germany, Austria, Australia, Britain, Armenia, Thailand, Russia, and additional nations. There was 171,828 visitors, underscoring its industry influence. Strategic Highlights for 2025: Buyer Engagement: Targeted outreach to importers (20.61%), distributors (22.94%), e-commerce platforms, and hospitality chains. Global Participation: Enhanced international pavilions and Hosted Buyer Program for key markets (USA, Italy, UK, ASEAN). Knowledge Hub: Concurrent forums on food e-commerce, sustainable catering, and retail innovation. Competitions: Features coffee series events endorsed by World Coffee Events, culinary competitions certified by the World Association of Chefs Societies, and other specialized event categories. We look forward to seeing you in November!
Korea Herald
2 hours ago
- Korea Herald
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
SEOUL, South Korea, July 1, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics. Designed as a real-time infectious disease intelligence system, the platform combines diagnostic data with advanced statistical modeling and aims to redefine how the world detects, tracks, and responds to outbreaks. STAgora™ provides real-time global visualization of infectious disease trends at the municipal, national, and continental levels, based on actual diagnostic test results. The platform delivers healthcare professionals immediate, structured diagnostic reports and statistical analyses in clear, actionable formats. These are supported by customizable dashboards and real-time alert functions. In addition to tracking individual cases, STAgora™ enables users to monitor outbreaks across selected regions, both local and international. This capability provides real-time visibility into disease spread, enhancing situational awareness and supporting timely, data-driven public health responses. By equipping national and global health authorities with real-time epidemiological insight, the platform is expected to strengthen decision-making and support the development of effective response strategies to mitigate large-scale infectious disease outbreaks. With more than 40 built-in statistical tools, STAgora™ enables early detection of abnormal pathogen patterns and supports predictive modeling for seasonal trends and emerging outbreaks. These tools include modules for tracking individual infections, analyzing symptom-based co-infections and calculating real-time infection rate trends. Together, they help transform static data into forward-looking intelligence that guides proactive interventions. Unlike traditional outbreak monitoring systems that rely on retrospective data, STAgora™ performs real-time analysis of PCR-derived diagnostics. This allows for immediate visibility into pathogen spread and, through AI-based algorithms, the forecasting of potential future outbreaks. "The key differentiator of STAgora™ is its unique architecture, which aggregates real-time diagnostic data from around the world into a unified analysis platform," said Young-Seag Baeg, head of strategic planning at Seegene. When paired with Seegene's proprietary syndromic quantitative PCR technology, STAgora™ offers expanded visibility into both single-pathogen infections and simultaneous multi-pathogen co-infections. This comprehensive diagnostic insight empowers clinicians to make faster, more informed decisions at the point of care. "During the COVID-19 pandemic, we saw firsthand how crucial accurate and timely interpretation of diagnostic data was in shaping public health policies and clinical outcomes," said Daniel Shin, executive vice president and chief global sales and marketing officer at Seegene. "Now, as we confront increasingly complex threats such as antimicrobial resistance, viral mutations and co-infections, the ability to deliver actionable insights from diagnostic data is becoming a cornerstone of clinical innovation and a vital pillar of global health security." Seegene will officially debut STAgora™ at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting, taking place July 27 to 31 in Chicago, USA. The event will highlight key capabilities of the platform, including its integration with CURECA™, Seegene's fully automated, unmanned PCR system. ADLM 2025 will also serve as a launchpad for Seegene to explore global collaboration and partnerships with healthcare leaders and clients. With the launch of STAgora™, Seegene aims to lay the foundation for a smarter, faster and more connected global health defense system. By combining real-time molecular diagnostics, AI-driven analytics and global data integration, STAgora™ represents a strategic step toward building an intelligent public health infrastructure capable of responding proactively to emerging threats. The company envisions the platform as a core pillar of the global infectious disease response framework, marking a new step toward enhanced diagnostic insight and preparedness. About Seegene Seegene has more than 20 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information. CURECA™(Continuous, Unlimited, Random-access, Expandable, and Customizable Automation) is a fully automated and modular PCR system that eliminates manual processes and enables continuous, real-time testing. It is a unified platform designed to operate continuously, 24 hours a day, with no human intervention. The very core feature is CPS which is the first part of CURECA™, the world's first automated pre-treatment system capable of handling a full spectrum of specimen types, including blood, stool, sputum, and urine. Designed to support both centralized and decentralized labs, CURECA offers scalable automation and flexible adoption—making it especially valuable in settings with limited space or personnel.
